News
Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...
Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...
Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...
LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...
Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Shares of Eli Lilly fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed ...
Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Cork Beo on MSN5h
Green light for $1bn expansion for at Eli Lilly's main Munster plant amidst tariff concernsLilly, which has its headquarters in Indianapolis, first announced that it would be seeking approval from Limerick City and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback